Tiziana Life Sciences Ltd. CEO Ivor Elrifi Tiziana Life Sciences appoints Ivor Elrifi as CEO NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human anti-CD3 monoclonal antibody, today announced […]